Nick van Boven
Overview
Explore the profile of Nick van Boven including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
144
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fusaroli M, Hoogendijk M, Bhagwandien R, Wijchers S, van Boven N, Mahmoodi B, et al.
J Interv Card Electrophysiol
. 2025 Jan;
PMID: 39797967
Introduction: A hybrid approach with very high-power short-duration (vHPSD) posteriorly and ablation-index guided HPSD (50 W) anteriorly seems to be an optimal balance between efficiency and effectiveness for point-by-point pulmonary...
2.
Klimczak-Tomaniak D, Andrzejczyk K, Abou Kamar S, Baart S, van Boven N, Akkerhuis K, et al.
Cardiol J
. 2024 Feb;
31(3):409-417.
PMID: 38408202
Background: Liver dysfunction contributes to worse clinical outcomes in heart failure (HF) patients. However, studies exploring temporal evolutions of liver function parameters in chronic HF (CHF) pa- tients, and their...
3.
Assaf A, van der Graaf M, van Boven N, van Ettinger M, Diletti R, Hoogendijk M, et al.
Int J Cardiol
. 2023 Jul;
390:131205.
PMID: 37482094
Background: The presence of an untreated chronic total coronary occlusion (CTO) is associated with a higher risk of ventricular arrhythmias (VAs). This increased risk may be modulated by the presence...
4.
Tomaniak M, Masdjedi K, Neleman T, Kucuk I, Vermaire A, van Zandvoort L, et al.
BMJ Open
. 2022 Apr;
12(4):e054202.
PMID: 35379622
Objectives: To evaluate the feasibility of three-vessel three-dimensional (3D) quantitative coronary angiography (QCA)-based fractional flow reserve (FFR) computation in patients discussed within the Heart Team in whom the treatment decision...
5.
Brankovic M, Akkerhuis K, Hoorn E, van Boven N, van den Berge J, Constantinescu A, et al.
Clin Cardiol
. 2020 Apr;
43(6):630-638.
PMID: 32298007
Background: It is uncertain that chronic heart failure (CHF) patients are susceptible to renal tubular damage with that of worsening renal function (WRF) preceding clinical outcomes. Hypothesis: Changes in tubular...
6.
Theuns D, van Boven N, Schaer B, Hesselink T, Rivero-Ayerza M, Umans V, et al.
J Card Fail
. 2019 Sep;
25(10):812-818.
PMID: 31479745
Background: The beneficial effects of a cardiac resynchronization defibrillator (CRT-D) in patients with heart failure, low left ventricular ejection fraction (LVEF), and wide QRS have clearly been established. Nevertheless, mortality...
7.
Bouwens E, Brankovic M, Mouthaan H, Baart S, Rizopoulos D, van Boven N, et al.
J Am Heart Assoc
. 2019 Feb;
8(4):e009555.
PMID: 30760105
Background Remodeling biomarkers carry high potential for predicting adverse events in chronic heart failure ( CHF ) patients. However, temporal patterns during the course of CHF , and especially the...
8.
van Boven N, Akkerhuis K, Umans V, Boersma E, Kardys I
Int J Cardiol
. 2019 Jan;
278:266.
PMID: 30683330
No abstract available.
9.
van Boven N, Battes L, Akkerhuis K, Rizopoulos D, Caliskan K, Anroedh S, et al.
Am Heart J
. 2018 Feb;
196:36-48.
PMID: 29421013
No abstract available.
10.
Brankovic M, Akkerhuis K, van Boven N, Anroedh S, Constantinescu A, Caliskan K, et al.
Kidney Int
. 2017 Dec;
93(4):952-960.
PMID: 29191357
Renal dysfunction is an important component of chronic heart failure (CHF), but its single assessment does not sufficiently reflect clinically silent progression of CHF prior to adverse clinical outcome. Therefore,...